Ondansetron Tablet, Orally Disintegrating
Product Images NDC 71335-2635

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71335-2635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352635)

Label for Ondansetron Orally Disintegrating Tablets USP 8 mg. The label shows the NDC 71335-2635-1, indicating 30 tablets. It is repackaged by Bryant Ranch Prepack, Burbank, CA, and manufactured by Glenmark Pharmaceuticals Limited. The label also includes storage instructions, a QR code for package insert, and warnings about tablet handling and child resistance.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure-base (Structure Base)

Chemical structure of ondansetron, showing the arrangement of its aromatic rings and heteroatoms in a 2D molecular diagram.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate, showing its molecular framework with fused rings, methyl groups, and the hydrochloride and hydrate components indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.